M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_25261

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_25261 44 0.91 Mlig455_017293

Neo: -

Age: -

 Mlig455_017293 {REF} {Length: 2262} {Pfam: Polycystin cation channel [PF08016.14, score=18.6]} {RNA1509_39680} {RNA1310_36220} {RNA815_1311.1}

Cumulative graph for MligTC455_25261

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -3.91 1.232 1.00000 1.00000
RegionR2 1.009 1.232 0.46761 0.85346
RegionR3 0.475 1.232 0.65195 1.00000
RegionR4 -0.053 1.232 0.82618 1.00000
RegionR5 1.066 1.232 0.39689 0.75348
RegionR6 2.44 1.232 0.04419 0.39309
RegionR7 2.275 1.232 0.12756 0.67282
RegionR8 -3.302 1.232 0.99970 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -0.384 1.232 1.00000 1.00000
RegenerationR2 -0.267 1.232 0.76494 0.97815
RegenerationR3 0.414 1.232 0.71423 0.95305
RegenerationR4 1.161 1.232 0.30107 0.74278
RegenerationR5 -1.391 1.232 0.21393 0.64895
RegenerationR6 -0.114 1.232 0.87450 1.00000
RegenerationBL -3.64 1.232 0.99978 1.00000
RegenerationTP 1.945 1.232 0.38284 0.81728


Genes with expression patterns similar to MligTC455_25261

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_25261 44 0.91 Mlig455_017293

Neo: -

Age: -

 2 - - - 1.000 1.000 - Mlig455_017293 {REF} {Length: 2262} {Pfam: Polycystin cation channel [PF08016.14, score=18.6]} {RNA1509_39680} {RNA1310_36220} {RNA815_1311.1}
2. MligTC455_33647 110 2.29 Mlig455_042597, Mlig455_042610, Mlig455_042641

Neo: -

Age: -

 0.983 - - - 0.983 - -

Mlig455_042597 {REF} {Length: 3620} {Dmel: FBgn0263993, CG43736, [RH, Score=83.6, Expect=5e-16]} {RNA1509_3896} {RNA1310_1327} {RNA815_6275}

Mlig455_042610 {REF} {Length: 3340} {Dmel: FBgn0263993, CG43736, [RH, Score=83.6, Expect=4e-16]} {RNA1509_57541} {RNA1310_1327} {RNA815_6275}

Mlig455_042641 {REF} {Length: 5491} {Dmel: FBgn0263993, CG43736, [RH, Score=83.6, Expect=5e-16]} {RNA1509_3896} {RNA1310_1327} {RNA815_2293.1}
3. MligTC455_24743 83 1.72 Mlig455_036269, Mlig455_054543, Mlig455_055397

Neo: -

Age: -

 FRK 0.978 - - - - 0.978 -

Mlig455_036269 {REF} {Length: 1873} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=319.6]; Protein kinase domain [PF00069.27, score=166.5]; SH2 domain [PF00017.26, score=62.6]; SH3 domain [PF00018.30, score=48.4]; Variant SH3 domain [PF14604.8, score=36.2]; Variant SH3 domain [PF07653.19, score=30.1]} {Human: ENSG00000111816, FRK, fyn related Src family tyrosine kinase, [RH, Score=523, Expect=0.0]; ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [RH, Score=507, Expect=4e-174]; ENSG00000197122, SRC, SRC proto-oncogene, non-receptor tyrosine kinase, [RH, Score=498, Expect=1e-170]; ENSG00000176105, YES1, YES proto-oncogene 1, Src family tyrosine kinase, [RH, Score=498, Expect=2e-170]} {Mouse: ENSMUSG00000019779, Frk, fyn-related kinase, [RH, Score=520, Expect=1e-179]; ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [RH, Score=507, Expect=4e-174]; ENSMUSG00000027646, Src, Rous sarcoma oncogene, [RH, Score=498, Expect=8e-171]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [RH, Score=496, Expect=8e-170]} {Dmel: FBgn0264959, Src42A, Src oncogene at 42A, [RH, Score=578, Expect=0.0]} {Celegans: WBGene00005078, src-2, Tyrosine protein-kinase src-2, [RH, Score=533, Expect=0.0]} {Smed: dd_Smed_v6_5635_0_1, dd_Smed_v6_5635_0_1, [Score=454, Expect=2e-152]} {RNA1509_22151} {RNA1310_3620} {RNA815_4026}

Mlig455_054543 {REF} {Length: 2477} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=319.6]; Protein kinase domain [PF00069.27, score=166.5]; SH2 domain [PF00017.26, score=62.6]; SH3 domain [PF00018.30, score=48.4]; Variant SH3 domain [PF14604.8, score=36.2]; Variant SH3 domain [PF07653.19, score=30.1]} {Human: ENSG00000111816, FRK, fyn related Src family tyrosine kinase, [RH, Score=523, Expect=0.0]; ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [RH, Score=507, Expect=4e-174]; ENSG00000197122, SRC, SRC proto-oncogene, non-receptor tyrosine kinase, [RH, Score=498, Expect=1e-170]; ENSG00000176105, YES1, YES proto-oncogene 1, Src family tyrosine kinase, [RH, Score=498, Expect=2e-170]} {Mouse: ENSMUSG00000019779, Frk, fyn-related kinase, [RH, Score=520, Expect=1e-179]; ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [RH, Score=507, Expect=4e-174]; ENSMUSG00000027646, Src, Rous sarcoma oncogene, [RH, Score=498, Expect=8e-171]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [RH, Score=496, Expect=8e-170]} {Dmel: FBgn0264959, Src42A, Src oncogene at 42A, [RH, Score=578, Expect=0.0]} {Celegans: WBGene00005078, src-2, Tyrosine protein-kinase src-2, [RH, Score=533, Expect=0.0]} {Smed: dd_Smed_v6_5635_0_1, dd_Smed_v6_5635_0_1, [Score=454, Expect=2e-152]} {RNA1509_22151} {RNA1310_9107} {RNA815_4026}

Mlig455_055397 {REF} {Length: 2220} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=319.4]; Protein kinase domain [PF00069.27, score=166.2]; SH2 domain [PF00017.26, score=62.6]; SH3 domain [PF00018.30, score=48.4]; Variant SH3 domain [PF14604.8, score=36.2]; Variant SH3 domain [PF07653.19, score=30.1]} {Human: ENSG00000111816, FRK, fyn related Src family tyrosine kinase, [RH, Score=523, Expect=0.0]; ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [RH, Score=507, Expect=5e-174]; ENSG00000197122, SRC, SRC proto-oncogene, non-receptor tyrosine kinase, [RH, Score=498, Expect=1e-170]; ENSG00000176105, YES1, YES proto-oncogene 1, Src family tyrosine kinase, [RH, Score=498, Expect=3e-170]} {Mouse: ENSMUSG00000019779, Frk, fyn-related kinase, [RH, Score=520, Expect=1e-179]; ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [RH, Score=506, Expect=6e-174]; ENSMUSG00000027646, Src, Rous sarcoma oncogene, [RH, Score=498, Expect=1e-170]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [RH, Score=496, Expect=1e-169]} {Dmel: FBgn0264959, Src42A, Src oncogene at 42A, [RH, Score=578, Expect=0.0]} {Celegans: WBGene00005078, src-2, Tyrosine protein-kinase src-2, [RH, Score=533, Expect=0.0]} {Smed: dd_Smed_v6_5635_0_1, dd_Smed_v6_5635_0_1, [Score=453, Expect=3e-152]} {RNA1509_22151, RNA1509_59446} {RNA1310_9107, RNA1509_22151, RNA1509_59446} {RNA1509_22151, RNA1509_59446, RNA815_4026}
4. MligTC455_35276 20 0.41 Mlig455_026610, Mlig455_042800

Neo: -

Age: -

 0.966 - - - - 0.966 -

Mlig455_026610 {REF} {Length: 2086} {RNA1310_18660} {RNA815_15449}

Mlig455_042800 {REF} {Length: 2333} {RNA1310_18660} {RNA815_15449}
5. MligTC455_04677 13 0.27 Mlig455_038295

Neo: -

Age: -

 0.962 - - - - 0.962 - Mlig455_038295 {REF} {Length: 672} {NoTransDecoderORF} {RNA1310_81030.1} {RNA815_40846}
6. MligTC455_06294 84 1.75 Mlig455_015683, Mlig455_015693, Mlig455_062494

Neo: -

Age: -

Region-enriched R4: 6.213/0.00616

 HOXA1 0.961 - - - - 0.961 -

Mlig455_015683 {REF} {Length: 764} {Pfam: Homeodomain [PF00046.31, score=79.1]} {Human: ENSG00000105991, HOXA1, homeobox A1, [Score=109, Expect=2e-28]; ENSG00000128645, HOXD1, homeobox D1, [Score=107, Expect=1e-27]} {Mouse: ENSMUSG00000029844, Hoxa1, homeobox A1, [Score=110, Expect=1e-28]; ENSMUSG00000042448, Hoxd1, homeobox D1, [Score=108, Expect=5e-28]} {Dmel: FBgn0002522, lab, labial, [Score=100, Expect=5e-26]} {Celegans: WBGene00000436, ceh-12, Homeobox protein ceh-12, [Score=75.5, Expect=3e-18]} {Smed: dd_Smed_v6_62255_0_1, dd_Smed_v6_62255_0_1, [Score=108, Expect=3e-30]} {RNA1310_90246} {RNA815_64639}

Mlig455_015693 {REF} {Length: 838} {Pfam: Homeodomain [PF00046.31, score=79.0]} {Human: ENSG00000105991, HOXA1, homeobox A1, [Score=108, Expect=5e-28]; ENSG00000128645, HOXD1, homeobox D1, [Score=107, Expect=2e-27]; ENSG00000120094, HOXB1, homeobox B1, [Score=103, Expect=4e-26]} {Mouse: ENSMUSG00000029844, Hoxa1, homeobox A1, [Score=108, Expect=5e-28]; ENSMUSG00000042448, Hoxd1, homeobox D1, [Score=108, Expect=6e-28]} {Dmel: FBgn0002522, lab, labial, [Score=99.8, Expect=7e-26]} {Celegans: WBGene00000436, ceh-12, Homeobox protein ceh-12, [Score=75.1, Expect=5e-18]} {Smed: dd_Smed_v6_62255_0_1, dd_Smed_v6_62255_0_1, [Score=110, Expect=1e-30]} {RNA1310_90246} {RNA815_64639}

Mlig455_062494 {REF} {Length: 770} {Pfam: Homeodomain [PF00046.31, score=79.1]} {Human: ENSG00000105991, HOXA1, homeobox A1, [Score=109, Expect=2e-28]; ENSG00000128645, HOXD1, homeobox D1, [Score=107, Expect=1e-27]} {Mouse: ENSMUSG00000029844, Hoxa1, homeobox A1, [Score=110, Expect=1e-28]; ENSMUSG00000042448, Hoxd1, homeobox D1, [Score=108, Expect=5e-28]} {Dmel: FBgn0002522, lab, labial, [Score=100, Expect=5e-26]} {Celegans: WBGene00000436, ceh-12, Homeobox protein ceh-12, [Score=75.5, Expect=3e-18]} {Smed: dd_Smed_v6_62255_0_1, dd_Smed_v6_62255_0_1, [Score=108, Expect=3e-30]} {RNA1310_90246} {RNA815_64639}
7. MligTC455_04625 54 1.12 Mlig455_031551, Mlig455_031554

Neo: -

Age: -

 FHAD1 0.96 - - - - 0.960 -

Mlig455_031551 {REF} {Length: 1252} {Pfam: FHA domain [PF00498.28, score=38.1]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.3]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=66.2, Expect=1e-11]} {RNA1509_11172} {RNA1310_2117.1} {RNA815_31030}

Mlig455_031554 {REF} {Length: 5287} {Pfam: FHA domain [PF00498.28, score=36.7]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.0]} {Human: ENSG00000142621, FHAD1, forkhead associated phosphopeptide binding domain 1, [Score=130, Expect=4e-31]} {Mouse: ENSMUSG00000051435, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=129, Expect=1e-29]; ENSMUSG00000116181, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=129, Expect=1e-29]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=252, Expect=3e-68]} {RNA1509_11172} {RNA1310_2117.1} {RNA815_6949}
8. MligTC455_28236 57 1.19 Mlig455_006755, Mlig455_054681

Neo: -

Age: -

 0.959 - - - - 0.959 -

Mlig455_006755 {REF} {Length: 1436} {NoTransDecoderORF} {RNA1509_44500} {RNA1310_4439.1} {RNA815_12729}

Mlig455_054681 {REF} {Length: 1105} {NoTransDecoderORF} {RNA1509_2932} {RNA1310_4439.1} {RNA815_1450.1}
9. MligTC455_09087 23 0.47 Mlig455_013470

Neo: -

Age: -

 0.955 - - - - 0.955 - Mlig455_013470 {REF} {Length: 218} {NoTransDecoderORF} {RNA1310_67024} {RNA815_18239}
10. MligTC455_36334 30 0.62 Mlig455_041900

Neo: -

Age: Up-Up-Down

Region-enriched R2: 9.749/0.00702

 URGCP 0.955 - - - - 0.955 - Mlig455_041900 {REF} {Length: 7730} {Pfam: Dynamin family [PF00350.25, score=22.8]; 50S ribosome-binding GTPase [PF01926.25, score=20.2]} {Human: ENSG00000106608, URGCP, upregulator of cell proliferation, [RH, Score=216, Expect=4e-57]} {Mouse: ENSMUSG00000078606, Gm4070, predicted gene 4070, [RH, Score=527, Expect=1e-154]; ENSMUSG00000045868, Gvin1, GTPase, very large interferon inducible 1, [RH, Score=527, Expect=1e-154]} {RNA1509_40173} {RNA1310_4704.1, RNA1509_40173} {RNA1509_40173, RNA815_32622}
11. MligTC455_50541 82 1.71 Mlig455_010939

Neo: -

Age: Down-Down-Up

 NFIA 0.955 - - - - 0.955 - Mlig455_010939 {REF} {Length: 3569} {Human: ENSG00000162599, NFIA, nuclear factor I A, [Score=85.1, Expect=1e-16]; ENSG00000147862, NFIB, nuclear factor I B, [Score=84.3, Expect=2e-16]; ENSG00000008441, NFIX, nuclear factor I X, [Score=82.4, Expect=7e-16]; ENSG00000141905, NFIC, nuclear factor I C, [Score=81.6, Expect=1e-15]} {Mouse: ENSMUSG00000028565, Nfia, nuclear factor I/A, [Score=84.7, Expect=9e-17]; ENSMUSG00000008575, Nfib, nuclear factor I/B, [Score=84.3, Expect=1e-16]; ENSMUSG00000055053, Nfic, nuclear factor I/C, [Score=83.2, Expect=2e-16]; ENSMUSG00000001911, Nfix, nuclear factor I/X, [Score=81.6, Expect=9e-16]} {Dmel: FBgn0042696, NfI, Nuclear factor I, [Score=84.7, Expect=1e-16]} {Celegans: WBGene00003592, nfi-1, NFI (Nuclear Factor I) family, [Score=90.9, Expect=1e-18]} {Smed: dd_Smed_v6_12312_0_1, dd_Smed_v6_12312_0_1, [Score=151, Expect=8e-38]} {RNA1310_40008.1} {RNA815_37863}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA